Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis
- PMID: 24143875
- PMCID: PMC3853321
- DOI: 10.1186/2046-4053-2-95
Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis
Abstract
Background: There is considerable unexplained heterogeneity in previous meta-analyses of randomized controlled trials (RCTs) evaluating the effects of patient decision aids on the accuracy of knowledge of outcome probabilities. The purpose of this review was to explore possible effect modification by three covariates: the type of control intervention, decision aid quality and patients' baseline knowledge of probabilities.
Methods: A sub-analysis of studies previously identified in the 2011 Cochrane review on decision aids for people facing treatment and screening decisions was conducted. Additional unpublished data were requested from relevant study authors to maximize the number of eligible studies. RCTs (to 2009) comparing decision aids with standardized probability information to control interventions (lacking such information) and assessing the accuracy of patient knowledge of outcome probabilities were included. The proportions of patients with accurate knowledge of outcome probabilities in each group were converted into relative effect measures. Intervention quality was assessed using the International Patient Decision Aid Standards instrument (IPDASi) probabilities domain.
Results: A main effects analysis of 17 eligible studies confirmed that decision aids significantly improve the accuracy of patient knowledge of outcome probabilities (relative risk = 1.80 [1.51, 2.16]), with considerable heterogeneity (87%). The type of control did not modify effects. Meta-regression suggested that the IPDASi probabilities domain score (reflecting decision aid quality) is a potential effect modifier (P = 0.037), accounting for a quarter of the variability (R² = 0.28). Meta-regression indicated the control event rate (reflecting baseline knowledge) is a significant effect modifier (P = 0.001), with over half the variability in ln(OR) explained by the linear relationship with log-odds for the control group (R² = 0.52); this relationship was slightly strengthened after correcting for the statistical dependence of the effect measure on the control event rate.
Conclusions: Patients' baseline level of knowledge of outcome probabilities is an important variable that explains the heterogeneity of effects of decision aids on improving accuracy of this knowledge. Greater relative effects are observed when the baseline proportion of patients with accurate knowledge is lower. This may indicate that decision aids are more effective in populations with lower knowledge.
Figures




Similar articles
-
Quality of decision aids developed for women at average risk of breast cancer eligible for mammographic screening: Systematic review and assessment according to the International Patient Decision Aid Standards instrument.Cancer. 2020 Jun 15;126(12):2765-2774. doi: 10.1002/cncr.32858. Epub 2020 Apr 8. Cancer. 2020. PMID: 32267546
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
The Effect of Patient Decision Aid Attributes on Patient Outcomes: A Network Meta-Analysis of a Systematic Review.Med Decis Making. 2025 May;45(4):437-448. doi: 10.1177/0272989X251318640. Epub 2025 Feb 19. Med Decis Making. 2025. PMID: 39968925 Free PMC article.
-
Effectiveness of decision aids for smoking cessation in adults: a quantitative systematic review.JBI Database System Rev Implement Rep. 2018 Sep;16(9):1791-1822. doi: 10.11124/JBISRIR-2017-003698. JBI Database System Rev Implement Rep. 2018. PMID: 30204670
-
Web-based decision aids to support breast cancer screening decisions: systematic review and meta-analysis.J Comp Eff Res. 2020 Oct;9(14):985-1002. doi: 10.2217/cer-2020-0052. Epub 2020 Oct 7. J Comp Eff Res. 2020. PMID: 33025800
Cited by
-
Effectiveness of a decision aid for promoting colorectal cancer screening in Spain: a randomized trial.BMC Med Inform Decis Mak. 2019 Jan 10;19(1):8. doi: 10.1186/s12911-019-0739-6. BMC Med Inform Decis Mak. 2019. PMID: 30630487 Free PMC article. Clinical Trial.
-
Eggsurance? A randomized controlled trial of a decision aid for elective egg freezing.Hum Reprod. 2024 Aug 1;39(8):1724-1734. doi: 10.1093/humrep/deae121. Hum Reprod. 2024. PMID: 38876980 Free PMC article. Clinical Trial.
-
Decision aids for people facing health treatment or screening decisions.Cochrane Database Syst Rev. 2024 Jan 29;1(1):CD001431. doi: 10.1002/14651858.CD001431.pub6. Cochrane Database Syst Rev. 2024. PMID: 38284415 Free PMC article.
-
Decision coaching for people making healthcare decisions.Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013385. doi: 10.1002/14651858.CD013385.pub2. Cochrane Database Syst Rev. 2021. PMID: 34749427 Free PMC article.
-
The evidence gap on gendered impacts of performance-based financing among family physicians for chronic disease care: a systematic review reanalysis in contexts of single-payer universal coverage.Hum Resour Health. 2020 Sep 22;18(1):69. doi: 10.1186/s12960-020-00512-9. Hum Resour Health. 2020. PMID: 32962707 Free PMC article.
References
-
- Higgins JPT, Green S, editor. The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons, Ltd; 2006. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6.
-
- Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is ‘quality of evidence’ and why is it important to clinicians? BMJ. 2008;336:995–998. doi: 10.1136/bmj.39490.551019.BE. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources